Akums Drugs and Pharmaceuticals Ltd AKUMS.NS
₹464.00 ₹6.00 (1.28%) 1D

Last Updated: Feb 12, 12:00 AM·NSE

AKUMS.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: December 16, 2025

Report Source: 2026 2nd Quarter Report

Analyst's Ratings for Akums Drugs and Pharmaceuticals Ltd (AKUMS.NS)

Based on 10 analysts giving stock ratings to Akums Drugs and Pharmaceuticals Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy
Strong Buy
40
Buy
50
Hold
10
Sell
0
Strong Sell
0
Akums Drugs and Pharmaceuticals Ltd

Akums Drugs and Pharmaceuticals Ltd. Stock Analysis AKUMS.NS

India Health Care Small Cap Report:
Akums Drugs & Pharmaceuticals Ltd. engages in the manufacturing and marketing of pharmaceutical products and services. The company is headquartered in Delhi, Delhi and currently employs 7,536 full-time employees. The company went IPO on 2024-08-06. The firm offers a comprehensive range of pharmaceutical products and services in India and overseas. The Company’s segments include Contract Development and Manufacturing Operations (CDMO), Active Pharmaceutical Ingredient (API), Domestic Branded Formulations, International Branded Formulations, and Trade Generics. The CDMO segment is engaged in formulation research and development, preparation and regulatory filing of dossiers, manufacturing formulations on a contract basis, job work and testing services. The API segment is engaged in the manufacture and sale of key starting materials, Intermediate and API products. The Domestic Branded Formulations segment includes marketing of its branded formulations in the Indian market. The International Branded Formulations segment undertakes the marketing of its branded formulations in the global market.
Read More

Akums Drugs and Pharmaceuticals Ltd (AKUMS.NS) Chart

Akums Drugs and Pharmaceuticals Ltd (AKUMS.NS) vs Nifty 50 Comparative Returns

Analysis of Akums Drugs and Pharmaceuticals Ltd (AKUMS.NS) stock performance compared to the broader market (Nifty 50) across multiple timeframes.

YTD Performance
  • Akums Drugs and... (AKU...) 2.34%
  • Nifty 50 -2.73%
Akums Drugs and... Outperformed Nifty 50 by 5.07%
1Y Performance
  • Akums Drugs and... (AKU...) -15.63%
  • Nifty 50 9.8%
Akums Drugs and... Underperformed Nifty 50 by 25.43%
3Y Performance
  • Akums Drugs and... (AKU...) %
  • Nifty 50 44.11%
Akums Drugs and... Underperformed Nifty 50 by N/A%
5Y Performance
  • Akums Drugs and... (AKU...) %
  • Nifty 50 86.54%
Akums Drugs and... Underperformed Nifty 50 by N/A%

Key Statistics of Akums Drugs and Pharmaceuticals Ltd (AKUMS.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹462.80₹472.10

Today's Open

₹470.00

Volume

62.35K

P/E Ratio (TTM)

21.93

52 Week Range

₹405.00₹622.95

Market Cap

69.28B

Avg. Volume

103.48K

Dividend Yield

-

Financial Metrics & Statements of Akums Drugs and Pharmaceuticals Ltd (AKUMS.NS)

Community-Curated Collections with Akums Drugs and Pharmaceuticals Ltd (AKUMS.NS) ( With AKUMS.NS )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

India Halal stock pharma

By Abubakar Siddique

11 Followers

  • Sun Pharmaceutical Industries Ltd
  • Divi's Laboratories Ltd
  • Cipla Ltd
+53 more
Mohammad Marediya

By M.J Marediya

6 Followers

  • Honeywell Automation India Ltd
  • Lodha Developers Ltd
  • Minda Corporation Ltd
+197 more
All Halal Stocks Only A CLASS

By Nazheem Ibrahim

0 Followers

  • Filatex Fashions Ltd
  • S
  • Risa International Ltd
+642 more

FAQ's for Akums Drugs and Pharmaceuticals Ltd (AKUMS.NS)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.

Related Halal Stocks to Akums Drugs and Pharmaceuticals Ltd (AKUMS.NS)

Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.

Name Price 1D Change Market Cap Rating
Divi's Laboratories Ltd

DIVISLAB.NS

₹6,185.00
4.08%
₹1.61T
Unlock
Syngene International Ltd

SYNGENE.NS

₹446.35
2.39%
₹190.87B
Unlock
Sai Life Sciences Ltd

SAILIFE.NS

₹930.00
1.78%
₹176.42B
Unlock
Onesource Specialty Pharma Ltd

ONESOURCE.NS

₹1,211.30
1.65%
₹135.97B
Unlock
Indegene Ltd

INDGN.NS

₹470.75
0.53%
₹115.95B
Unlock
Innova Captab Ltd

INNOVACAP.NS

₹691.70
0.44%
₹39.71B
Unlock
Vimta Labs Ltd

VIMTALABS.NS

₹490.70
1.18%
₹18.36B
Unlock
Windlas Biotech Ltd

WINDLAS.NS

₹799.00
0.43%
₹16.62B
Unlock
Tarsons Products Ltd

TARSONS.NS

₹201.02
4.03%
₹10.32B
Unlock
Borosil Scientific Ltd

BOROSCI.NS

₹116.55
7.94%
₹9.77B
Unlock
Brooks Laboratories Ltd

BROOKS.NS

₹76.51
0.64%
₹1.82B
Unlock
S
Samsrita Labs Ltd

539267.BO

₹17.94
0.55%
₹488.76M
Unlock
Form CRS
|
SEC Registered Investment Advisor (IAPD)
|
FINRA Broker Check
Halal trading platform offered by Musaffa LLC, which operates the Musaffa halal investment digital platform (“Platform”), is not a broker-dealer and has entered into a clearing agreement with ALPACA SECURITIES LLC (“Alpaca Securities”), a member of FINRA and Securities Investor Protection Corporation (SIPC) . Review our fee schedule for more information.
Investment management and advisory services offered by Musaffa LLC, a U.S. SEC Registered Investment Advisor (RIA) - (CRD # 338525 / SEC#:801-134527 ). Such registration should in no way imply that the SEC has endorsed entities, products, or services discussed herein. Musaffa does not provide, solicit, or execute any securities transactions. Registration as an RIA does not imply a certain level of skill or training. Review the company’s brochure for more information regarding the services, fees, risks, and conflicts of interest.
All investments involve risk, including the potential loss of principal. The value of securities and other investments may fluctuate due to market conditions, economic factors, or other external influences, and past performance is not indicative of future results. The materials, data, and information made available on the Platform are provided solely for general informational and educational purposes and shall not be construed as investment advice, a recommendation to buy or sell any security, or a solicitation to engage in any transaction. Users are solely responsible for their investment decisions and are strongly encouraged to seek independent legal, financial, and tax advice before making any investment.
Musaffa does not guarantee the accuracy, timeliness, or completeness of any information made available on the Platform. Information is subject to change without notice. Reasonable efforts are made to maintain the integrity of the content; however, Musaffa assumes no responsibility for errors, misprints, or out-of-date information provided on the Platform. The Platform may include data, products, services, or other content provided by third-party sources. Musaffa does not control or assume responsibility for any third-party content. All products, services, and content obtained from third-party content are provided “as is” without warranty of any kind, express or implied, including, but not limited to, implied warranties of merchantability, fitness for a particular purpose, title, non-infringement, security, or accuracy.
PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE, YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.
All trademarks, service marks, trade names, and logos displayed on the Platform are the property of their respective owners. References to third-party products, services, or providers do not constitute endorsement or recommendation by Musaffa.
Please visit our Disclosures Library for further information.
DMCA.com Protection Status

Musaffa® is a registered trademark of Musaffa, Inc. All rights reserved.

The term halal, when applied to investments, is subject to multiple interpretations. We define halal investments as investments permitted by Shariah law. Shariah-compliant investments are investment products governed by the requirements of Shariah law and the principles of the Islamic religion.
*#1 Website in the Halal Investment Research: Per web analytics of Similarweb, Semrush, and Similar Sites in comparison to competitors for the year of 2024.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.